DE602004029373D1 - METHOD FOR REMOVING THE TRIPHENYLMETHANE GRIP - Google Patents

METHOD FOR REMOVING THE TRIPHENYLMETHANE GRIP

Info

Publication number
DE602004029373D1
DE602004029373D1 DE602004029373T DE602004029373T DE602004029373D1 DE 602004029373 D1 DE602004029373 D1 DE 602004029373D1 DE 602004029373 T DE602004029373 T DE 602004029373T DE 602004029373 T DE602004029373 T DE 602004029373T DE 602004029373 D1 DE602004029373 D1 DE 602004029373D1
Authority
DE
Germany
Prior art keywords
sup
triphenylmethane
grip
ring
tetrazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004029373T
Other languages
German (de)
Inventor
Stanislav Radl
Jan Stach
Ondrej Klecan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20032319A external-priority patent/CZ297016B6/en
Priority claimed from CZ20040733A external-priority patent/CZ298329B6/en
Application filed by Zentiva KS filed Critical Zentiva KS
Publication of DE602004029373D1 publication Critical patent/DE602004029373D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

A method of removing the triphenylmethane protecting group from 1-triphenylmethy1-5-(4'-subst. methyl-1,1'-biphenyl-2-yl)-1H-tetrazoles of general formula I wherein R represents the groups of formulae and where R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>can be H, a halogen, an unbranched or branched C1-C5 alkyl, C1-C5 hydroxyalkyl, C1-C5 alkoxy, C1-C5 alkoxymethyl or benzyl, or wherein R<SUP>2 </SUP>and R<SUP>3 </SUP>can form together a saturated or unsaturated C5-C7 ring, optionally an unsubstituted or substituted aromatic ring, is carried out by solvolysis in a simple anhydrous C1 to C5 alcohol in a neutral or slightly basic medium. The method is suitable for the preparation of drugs, such as the potassium salts of losartan, irbesartan or valsartan or candesartan cilexetil.
DE602004029373T 2003-08-27 2004-08-26 METHOD FOR REMOVING THE TRIPHENYLMETHANE GRIP Active DE602004029373D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20032319A CZ297016B6 (en) 2003-08-27 2003-08-27 Method for removing triphenylmethane protecting group from 1-trityl-5-(4'-substituted aminomethyl-1,1' -biphenyl-2-yl)-1H-tetrazoles and process for preparing losartan, irbesartan and valsartan potassium salt by making use thereof
CZ20040733A CZ298329B6 (en) 2004-06-16 2004-06-16 Process for preparing 1-(cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2??-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate (candesartan cilexetil)
PCT/CZ2004/000051 WO2005021535A2 (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group

Publications (1)

Publication Number Publication Date
DE602004029373D1 true DE602004029373D1 (en) 2010-11-11

Family

ID=34276338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029373T Active DE602004029373D1 (en) 2003-08-27 2004-08-26 METHOD FOR REMOVING THE TRIPHENYLMETHANE GRIP

Country Status (13)

Country Link
US (1) US20060287537A1 (en)
EP (1) EP1658281B1 (en)
AT (1) ATE482950T1 (en)
CA (1) CA2536781A1 (en)
DE (1) DE602004029373D1 (en)
EA (1) EA011507B1 (en)
ES (1) ES2348300T3 (en)
HR (1) HRP20060119A2 (en)
PL (2) PL1658281T3 (en)
PT (1) PT1658281E (en)
RS (1) RS20060125A (en)
SK (1) SK50142006A3 (en)
WO (1) WO2005021535A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
WO2006050922A1 (en) * 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
SI22127A (en) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Procedure of preparation of candesartan cilexetil
CZ299902B6 (en) * 2005-10-27 2008-12-29 Zentiva, A. S Method of removing triphenylmethane-protecting group from precursors of antihypertensive drugs
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
US8492577B2 (en) 2008-04-07 2013-07-23 Hetero Research Foundation Process for preparation of valsartan intermediate
WO2010046804A2 (en) * 2008-10-21 2010-04-29 Alembic Limited A process for preparation of losartan potassium form i
EP2432777A1 (en) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN103012382B (en) * 2012-12-05 2016-10-05 迪沙药业集团有限公司 A kind of preparation method of olmesartan medoxomil
SG11201702483QA (en) * 2014-09-29 2017-04-27 Scripps Research Inst Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE134624T1 (en) * 1990-02-19 1996-03-15 Ciba Geigy Ag ACYL COMPOUNDS
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
AT395853B (en) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh NEW IMIDAZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
EP1294712A1 (en) * 2001-05-18 2003-03-26 Aurobindo Pharma Limited Process for the crystallization of losartan potassium

Also Published As

Publication number Publication date
RS20060125A (en) 2008-06-05
HRP20060119A2 (en) 2006-05-31
SK50142006A3 (en) 2006-05-04
EP1658281B1 (en) 2010-09-29
EA011507B1 (en) 2009-04-28
WO2005021535A2 (en) 2005-03-10
PL379886A1 (en) 2006-11-27
PL1658281T3 (en) 2010-12-31
ATE482950T1 (en) 2010-10-15
EP1658281A2 (en) 2006-05-24
PT1658281E (en) 2010-10-12
ES2348300T3 (en) 2010-12-02
US20060287537A1 (en) 2006-12-21
CA2536781A1 (en) 2005-03-10
WO2005021535A3 (en) 2005-06-09
EA200600079A1 (en) 2006-08-25

Similar Documents

Publication Publication Date Title
DE602004029373D1 (en) METHOD FOR REMOVING THE TRIPHENYLMETHANE GRIP
RS53348B (en) Process for making 3-substituted 2-amino-5-halobenzamides
ES2531190T3 (en) Method to produce a 4-oxoquinoline compound
CL2011001586A1 (en) Method comprising a sulfoximide composition containing 6-haloalkylpyridin-3-yl-substituted alkyl; Composition comprising a stereoisomeric mixture of said sulfoximide in an aqueous pharmaceutical formulation.
SV2010003483A (en) FUSIONED BICYCLE PYRIMIDINS
CO5601030A2 (en) DERIVATIVES OF QUINOLINONA / BENZOXAZINONA AND USES OF THE SAME
CO6160235A2 (en) INSECTICIDE ISOXAZOLINS
AR082825A2 (en) HITEROCICLIC INHIBITORS NITROGENATED FROM MEK, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHODS TO PREPARE THEM AND USE OF THE SAME FOR THE TREATMENT OF HYPERPROLIFERATIVE OR INFLAMMATORY DISORDERS
CY1113676T1 (en) Substituted Beta-Finyl-Alpha-Hydroxy Propionic Acid, Method of Composition and Its Use
EA200802380A1 (en) JOINT CRYSTALS OF PYRROLIDINONES
NO20085269L (en) 2-thioxanthine derivatives which act as MPO inhibitors
ECSP088700A (en) 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AND 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AS INHIBITORS OF THE PLK1
UY31388A1 (en) METHOD FOR THE PRODUCTION OF 2´-DESOXI-5-AZACITIDINE (DECITABINE)
CO6321266A2 (en) LIMK2 INHIBITORS COMPOUNDS OF WHICH ARE MADE AND METHODOLOGY OF USE
EA201170595A1 (en) DERIVATIVE OF PHENANTROINDOLIZIDINE AND NFKB INHIBITOR CONTAINING IT AS AN ACTIVE INGREDIENT
WO2008136444A1 (en) Fused heterocyclic derivative
AR078142A1 (en) BICYCLE HYDEROARILIC PDE4 INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THE USE OF THEM FOR THE PREPARATION OF MEDICINES.
PE20091359A1 (en) PROCESS FOR THE PREPARATION OF INTERMEDIARY ORGANIC COMPOUNDS OF RENIN INHIBITORS
MX2009011076A (en) Therapeutic agent for glaucoma containing adenosine derivative as active ingredient.
EA201070010A1 (en) DERIVATIVES OF 7-ALKINYL-1,8-NAFTYRIDONES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
EA200970497A1 (en) PYRROLA DERIVATIVES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
AR077820A1 (en) JNK INHIBITORS
ME01157B (en) Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
NO20050391L (en) New Fluorinated Benzothiadiazine Compounds, Methods for their Preparation and Pharmaceutical Compositions Containing Them
CO6331469A2 (en) NOVELTY DERIVATIVES OF PIRAZOLONA AND ITS USE AS PD4 INHIBITORS